Evidence map›Paper›PMID 39535563›Full record

SynthesisCalcified tissue international2024

Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis Imperfecta.

Luca Celli, Mark R Garrelfs, Ralph J B Sakkers, Mariet W Elting, Mauro Celli, Arend Bökenkamp, Cas Smits, Thadé Goderie, Jan Maerten Smit, Lothar A Schwarte and 43 more

Abstract readSystematic Review
In one paragraph

Synthesis in Calcified tissue international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. What's New in Osteogenesis Imperfecta.Journal of the Pediatric Orthopaedic Society of North America · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors.

Luca CelliDepartment of Human Genetics, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
Mark R GarrelfsRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Ralph J B SakkersDepartment of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Mariet W EltingDepartment of Human Genetics, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
Mauro CelliRare Bone Diseases Center, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Arend BökenkampRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Cas SmitsOtolaryngology-Head and Neck Surgery, Section Ear and Hearing, Amsterdam UMC, Amsterdam, The Netherlands.
Thadé GoderieRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Jan Maerten SmitRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Lothar A SchwarteRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Patrick R SchoberRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Wouter D LubbersRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Marieke C VisserRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Arthur J KievitRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Barend J van RoyenRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Marjolijn GilijamseRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Willem H SchreuderRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Thomas RustemeyerRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Angela PramanaRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Jan-Jaap HendrickxRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Max R DaheleRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Peerooz SaeedRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Annette C MollRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Katie R Curro-TafiliRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Ebba A E GhyczyRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Chris DickhoffRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Robert A de LeeuwRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Jaap H BonjerRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Jakko A NieuwenhuijzenRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Thelma C KoningsRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Anton F EngelsmanRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Augustinus M EeckhoutRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Joost G van den AardwegRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Patrick J ThoralRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
David P NoskeRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Leander DuboisRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Berend P TeunissenRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Oliver SemlerDepartment of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Lena Lande WekreTRS National Resource Center for Rare Disorders, Sunnaas Rehabilitation Hospital, Oslo, Norway.
Katre MaasaluDepartment of Orthopaedics, University of Tartu, Tartu, Estonia.
Aare MärtsonDepartment of Orthopaedics, University of Tartu, Tartu, Estonia.
Luca SangiorgiDepartment of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Paolo VersacciDepartment of Materna Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Mara RiminucciDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Paola GrammaticoDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Anna ZambranoRare Bone Diseases Center, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Lorena MartiniDepartment of Orthopaedic and Traumatology, "Sapienza" University of Rome, Rome, Italy.
Marco CastoriDivision of Medical Genetics, Fondazione IRCCS-Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy.
Esmee BotmanRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Ingunn WesterheimOsteogenesis Imperfecta Federation Europe (OIFE), Heffen, Belgium.
Lidiia ZhytnikDepartment of Human Genetics, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
Dimitra MichaDepartment of Human Genetics, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
Elisabeth Marelise W EekhoffRare Bone Disease Center Amsterdam, Amsterdam, The Netherlands. emw.eekhoff@amsterdamumc.nl.ORCID 0000-0001-5399-676X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteogenesis Imperfecta (OI), known as "brittle bone disease," presents a rare genetic disorder characterized by bone fragility, often accompanied by skeletal deformities and extraskeletal complications. OI is primarily associated with collagen type I defects, responsible for the syndromic nature of the disease affecting a broad range of tissues. As such, its multisystemic complexity necessitates multidisciplinary care approaches in all patient life stages. OI treatment remains largely supportive, commonly including bisphosphonates and orthopedic surgeries, which show promise in children. Although rehabilitation programs for children exist, guidelines for adult care and especially the transition from pediatric to adult care, are lagging behind in OI care and research. The current systematic review summarizes the literature on OI patient pediatric to adult care transition experiences and compares OI transition approaches to other chronic diseases. The review was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Systematic searches were conducted across multiple databases. Search terms encompassed synonyms and closely related phrases relevant to "OI" and "Transition to adult care". The initial screening involved the evaluation of article titles, followed by a thorough review of abstracts to assess relevance for the purpose of the current review. Programs aimed at easing the transition from pediatric to adult OI care necessitate a multifaceted approach. Collaborative efforts between different medical disciplines including pediatricians, endocrinologists, orthopedics, cardiology, pulmonology, ophthalmology, otolaryngologists, maxillofacial specialists, psychologists and medical genetics, are crucial for addressing the diverse needs of OI patients during this critical life phase. Comprehensive education, readiness assessments, personalized transition plans, and further follow-up are essential components of a structured transition framework. Further research is warranted to evaluate the feasibility and efficacy of sequential stepwise transition systems tailored to individuals with OI.

Indexed as

Osteogenesis ImperfectaTransition to Adult CareAdultChildHumansAdult careContinuity of patient careMultidisciplinary careOsteogenesis imperfectaTransitional care

Identifiers

PMID39535563
PMCPMC11607004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.